These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 9638277)

  • 1. Novel saturated 1,2,4-trioxanes and their antimalarial activity against multidrug resistant Plasmodium yoelii nigeriensis in Swiss mice model via oral route.
    Kumari A; Yadav P; Rawat V; Maurya RA; Islam MS; Eldesoky GE; Puri SK; Verma VP
    Bioorg Med Chem Lett; 2024 Aug; 108():129801. PubMed ID: 38777279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: Characteristics of splenic PD-1
    Chen D; Mo F; Liu M; Liu L; Xing J; Xiao W; Gong Y; Tang S; Tan Z; Liang G; Xie H; Huang J; Shen J; Pan X
    Immunol Res; 2024 Jun; 72(3):395. PubMed ID: 38421495
    [No Abstract]   [Full Text] [Related]  

  • 3. Repurposing Terfenadine as a Novel Antigiardial Compound.
    Suárez-Rico DO; Munguía-Huizar FJ; Cortés-Zárate R; Hernández-Hernández JM; González-Pozos S; Perez-Rangel A; Castillo-Romero A
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765140
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug repositioning: antiprotozoal activity of terfenadine against Entamoeba histolytica trophozoites.
    Rangel-Castañeda IA; Castillo-Romero A; León-Ávila G; Zermeño-Ruiz M; Hernández-Hernández JM
    Parasitol Res; 2022 Jan; 121(1):303-309. PubMed ID: 34741218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Drugs to Fight Hepatic Malaria Parasites.
    Fontinha D; Moules I; Prudêncio M
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32731386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel potassium channel (GiK) as a potential drug target in
    Palomo-Ligas L; Gutiérrez-Gutiérrez F; Ochoa-Maganda VY; Cortés-Zárate R; Charles-Niño CL; Castillo-Romero A
    PeerJ; 2019; 7():e6430. PubMed ID: 30834181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells and histamine alter intestinal permeability during malaria parasite infection.
    Potts RA; Tiffany CM; Pakpour N; Lokken KL; Tiffany CR; Cheung K; Tsolis RM; Luckhart S
    Immunobiology; 2016 Mar; 221(3):468-74. PubMed ID: 26626201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pre-emptive strike against malaria's stealthy hepatic forms.
    Mazier D; Rénia L; Snounou G
    Nat Rev Drug Discov; 2009 Nov; 8(11):854-64. PubMed ID: 19876040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.
    Hobbs CV; Voza T; Coppi A; Kirmse B; Marsh K; Borkowsky W; Sinnis P
    J Infect Dis; 2009 Jan; 199(1):134-41. PubMed ID: 19032102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
    Neerja J; Puri SK
    Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.
    Peters W; Ekong R; Robinson BL; Warhurst DC; Pan XQ
    Ann Trop Med Parasitol; 1990 Dec; 84(6):541-51. PubMed ID: 1981663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, Part 3: Observations on cyproheptadine, an antihistaminic agent, with chloroquine.
    Peters W; Robinson BL; Stewart LB; Butcher GA
    Ann Trop Med Parasitol; 2000 Oct; 94(7):689-97. PubMed ID: 11144810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal prophylactic activity of antihistaminic agents against Plasmodium yoelii nigeriensis infection in Swiss mice.
    Singh N; Puri SK
    Acta Trop; 1998 Jun; 69(3):255-60. PubMed ID: 9638277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the development of the hepatic stages of Plasmodium yoelii nigeriensis by antihistaminic agents.
    Singh N; Puri SK
    Ann Trop Med Parasitol; 1999 Jun; 93(4):419-22. PubMed ID: 10656045
    [No Abstract]   [Full Text] [Related]  

  • 16. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.